Related Experiment Video
Updated: Nov 30, 2025

05:37
Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes
Published on: April 4, 2025
1.1K
G-Quadruplexes Are Present in Human Coronaviruses Including SARS-CoV-2
Haoran Cui1,2, Leiliang Zhang1,2
1Institute of Basic Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
Frontiers in Microbiology
|November 16, 2020
Summary
This study predicts G-quadruplex sequences in all human coronaviruses, including SARS-CoV-2. Targeting these G-quadruplexes offers a potential new strategy to combat COVID-19.
Area of Science:
- Virology
- Genomics
- Molecular Biology
Background:
- The COVID-19 pandemic is caused by SARS-CoV-2, a human coronavirus.
- G-quadruplexes are known to impede genome replication.
- The presence of G-quadruplexes in human coronaviruses was previously unknown.
Purpose of the Study:
- To investigate the presence of G-quadruplex sequences in human coronaviruses.
- To analyze conserved G-quadruplex sequences in SARS-CoV and SARS-CoV-2.
- To explore G-quadruplexes as potential therapeutic targets for COVID-19.
Main Methods:
- Bioinformatic prediction of G-quadruplex sequences in all seven human coronaviruses.
- Experimental verification using circular dichroism (CD) spectroscopy.
- Thioflavin T fluorescence assay to confirm G-quadruplex presence.
- Analysis of nsP3 protein association with G-quadruplexes.
Main Results:
- G-quadruplex sequences were predicted in all seven human coronaviruses.
- Conserved G-quadruplex sequences were identified and verified in SARS-CoV and SARS-CoV-2.
- The nsP3 protein in SARS-CoV-2 is predicted to interact with G-quadruplexes.
Conclusions:
- Human coronaviruses, including SARS-CoV-2, harbor G-quadruplex sequences.
- These G-quadruplexes are conserved and can be experimentally verified.
- Targeting SARS-CoV-2 G-quadruplexes with specific ligands presents a novel therapeutic avenue for COVID-19 treatment.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
17.5K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.5K
Viruses with RNA Genomes
464
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
464
Leaky Scanning
5.5K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.5K
Size and Structure of Viral Genomes
468
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
468
Rous Sarcoma Virus (RSV) and Cancer
5.8K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.8K
Viral Recombination
24.5K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.5K

